To everyone questioning the false positive and false negative rates: your point is well-taken, and it is the reason why it was necessary to push the FDA to allow non-CDC labs to perform COVID-19 testing based on a fast-tracked version of the clinical validation process.

To those that point out that there are newer/faster/better ways to actually achieve the same results: you're right but that doesn't mean that the machines, reagents, collection media, etc. are ready for prime time in this type of setting. Remember: the entire process needs to be clinically validated in order to earn the trust of doctors and public health officials who are literally making life vs. death decisions.

TL;DR - Your points are valid, and there are real challenges that make certain solutions impractical at this point in time. Consider this a call to action to entrepreneurs who are serious about helping patients at home and around the world.